APS 合并 Felty 综合征病例 1 例

Journal: Basic Medical Theory Research DOI: 10.12238/bmtr.v6i3.7496

杨柳

南部战区总医院

Abstract

目的:探讨1例自身免疫多内分泌腺病(autoimmune olyglandular syndrome,APS)合并Felty综合征(Felty’s syndrome,FS)的临床特点。明确诊断及预防的重要性,探讨可能的致病基因。方法:回顾性分析1例APS合并FS的临床资料,结合文献复习。结果:APS合并FS在临床中较为罕见,国内外首次报道。患者存在1型糖尿病和自身免疫型甲状腺炎,既往病史存在FS,目前予以胰岛素,甲状腺素替代治疗,补充造血原料。结论:APS2合并FS临床上十分罕见,HLA-DRB1*04等位基因可能是致病基因,治疗上主要以激素替代治疗为主,临床上应及时结合关节表现早期诊断,改善患者预后。

Keywords

自身免疫性多内分泌腺病综合征

References

[1] Husebye E S, Anderson M S. Autoimmune polyendocrine syndromes:clues to type 1 diabetes pathogenesis[J]. Immunity, 2010,32(4):479-487.
[2] Dwivedi N, Upadhyay J, Neeli I, et al. Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps[J].Arthritis Rheum,2012,64(4):982-992.
[3] Freeman N S P R. Felty’s syndrome[J]. Oral Surgery, Oral Medicine,Oral Pathology,1975:409-413.
[4] Wemeau J L, Proust-Lemoine E, Ryndak A, et al. Thyroid autoimmunity and polyglandular endocrine syndromes[J]. Hor
[5] Cheng M H, Anderson M S. Insights into type 1 diabetes from the autoimmune polyendocrine syndromes[J]. Curr Opin Endocrinol Diabetes Obes,2013,20(4):271-278.
[6] Liu Y F, Powrie J, Arif S, et al. Immune and Metabolic Effects of Antigen-Specific Immunotherapy Using Multiple beta-Cell Peptides in Type 1 Diabetes[J]. Diabetes,2022,71(4):722-732.
[7] Bratland E, Skinningsrud B, Undlien D E, et al. T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency[J]. J Clin Endocrinol Metab,2009,94(12):5117-5124.
[8] Ueda H, Howson J M, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoi mmune disease[J].Nature,2003,423(6939):506-511.
[9] 吕丽娜,陶丽菊,王小超,等.Felty综合征1例并文献复习[J].右江民族医学院学报,2019,41(03):332-333.
[10] Turesson C, Schaid D J, Weyand C M, et al. The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritis[J]. Arthritis Res Ther,2005,7(6):R1386-R1393.
[11] 邓丽,陈娟,张佩莲.Felty综合征两例并文献复习[J].皮肤病与性病,2019,41(04):471-474.
[12] Lora V,Cerroni L,Cota C.Skin manifestations of rheum atoid arthritis[J]. G Ital Dermatol Venereol,2018,153(2):243-255.
[13] Liu J H,Wei S,Lamy T,etal.Chronic neutropenia mediat ed by fas ligand[J]. Blood,2000,95(10):3219-3222.
[14] Scherer H U, Haupl T, Burmester G R. The etiology of rheumatoid arthritis[J]. J Autoimmun,2020,110:102400.

Copyright © 2024 杨柳

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License